Symbolic image Collagen peptides for meniscopathy: RCT 2025
A new placebo-controlled study shows: collagen peptides can improve pain and function in meniscopathy. We put the evidence in context
In context
Peptide news
Research, regulation, safety and market around peptides - briefly contextualized and sourced.
48 posts ·continuously updated ·independent & ad-free
Symbolic image 
Symbolic image FDA: Navepegritide for Achondroplasia
The FDA has approved Navepegritide (YUVIWEL) as the first peptide for achondroplasia in children aged 2 and older. What this means for those affected
Symbolic image FDA approves Icotrokinra (ICOTYDE) as an oral peptide
FDA approves Icotrokinra (ICOTYDE) - the first oral peptide for plaque psoriasis. What this means for peptide users
Symbolic image FDA: New Guidelines for Peptide Generics
The FDA published 17 revised guidelines for generic peptides and withdrew the 2021 rule. This brings clarity for semaglutide and tirzepatide generics.
Symbolic image Bioactive peptides: From supplement to food
Bioactive peptides are moving from niche supplements into bars, drinks, and snacks. What this trend means for you and where regulation falls short
Symbolic image EMA guideline: Synthetic peptides from June 2026
The EMA guideline EMA/CHMP/CVMP/QWP/367182/2025 on synthetic peptides applies from 1 June 2026. This means stricter requirements for manufacturing and quality - also for you as a buyer
Symbolic image FDA peptides: Kennedy reshapes advisory committee
FDA scientists warn against expanded peptide access, but Kennedy's new panel recommends loosening. What that means for the market
Symbolic image Plant protein hydrolysates: satiety under test
A human study shows: bitter pea protein hydrolysates delay gastric emptying and reduce energy intake. We explain the mechanisms
Symbolic image AI finds bioactive peptides: What does that mean?
A new review shows how AI detects bioactive peptides in food. We explain what that means for your diet